Author

Raja Atreya 1

1 University Erlangen-Nuremberg,Erlangen,Germany

ANTI-TNF ALPHA THERAPY IN BIOLOGICS-NAϊVE ULCERATIVE COLITIS PATIENTS IN A PROSPECTIVE “REAL WORLD” STUDY IN GERMANY (BIOCOLITIS-REGISTRY)

Bernd Bokemeyer, Raja Atreya, Jürgen Büning, Tanja Kühbacher, Christian Maaser, Karen Schmidt, Petra Hartmann, Berit Wiebe, Stefan Schreiber

Assessing mucosal barrier function in vivo with confocal laser endomicroscopy can predict major clinical events in IBD patients with high sensitivity

Timo Rath, Entcho Klenske, Raja Atreya, Sarahh Fischer, Sebastian Zundler, Arndt Hartmann, Markus F. Neurath

BLOCKADE OF ?E?7 INTEGRIN CONTROLS TRAFFICKING OF CD8+ AND TH9 LYMPHOCYTES FROM IBD PATIENTS TO THE INFLAMED GUT IN VIVO

Sebastian Zundler, Anika Fischer, Raja Atreya, Rocío Lopez-Posadas, Alastair Watson, Clemens Neufert, Imke Atreya, Markus F. Neurath

CD4+ T CELLS OF IBD PATIENTS ARE CHARACTERIZED BY AN INCREASED EXPRESSION OF THE NUCLEOTIDE RECEPTOR P2Y2, WHICH IMPACTS RELEVANTLY ON PRO-INFLAMMATORY SIGNALING CASCADES.

Julia Panteleev-Ivlev, Sebastian Zundler, Raja Atreya, Markus Friedrich Neurath, Imke Atreya

CLINICAL DISEASE ACTIVITY INFLUENCES THE THERAPEUTIC EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya, Laurent Peyrin-Biroulet, Walter Reinisch, Franco Scaldaferri, Charlotte Admyre, Thomas Knittel, Jan Kowalski, Markus F. Neurath, Christopher John Hawkey

CLINICAL EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN ANTI-TNF-ANTIBODY TREATED AND NAIVE PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya

CLINICAL EFFICACY OF THE TOLL LIKE RECEPTOR-9 AGONIST COBITOLIMOD IN ANTI-TNF-ANTIBODY TREATED AND NAIVE PATIENTS WITH MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS

Raja Atreya, Walter Reinisch, Laurent Peyrin-Biroulet, Franco Scaldaferri, Charlotte Admyre, Thomas Knittel, Jan Kowalski, Christopher John Hawkey

COBITOLIMOD FOR MODERATE-TO-SEVERE LEFT-SIDED ULCERATIVE COLITIS (CONDUCT): A PHASE IIB, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL

Raja Atreya, Laurent Peyrin–Biroulet, Andrii Klymenko, Monica Augustyn, Igor Bakulin, Dusan Slankamenac, Pal Miheller, Antonio Gasbarrini, Xavier Hebuterne, Karin Arnesson, Thomas Knittel, Jan Kowalski, Markus F. Neurath, William Sandborn, Walter Reinisch

COBITOLIMOD FOR MODERATE-TO-SEVERE LEFT-SIDED ULCERATIVE COLITIS (CONDUCT): A PHASE IIB, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING TRIAL

Raja Atreya

CONFOCAL LASER ENDOMICROSCOPY PREDICTS RELEVANT CLINICAL OUTCOMES IN CROHN’S DISEASE: A PROSPECTIVE, OBSERVATIONAL, FOLLOW-UP STUDY.

Gian E. Tontini, Jonas Mudter, Michael Vieth, Raja Atreya, Claudia Günther, Maurizio Vecchi, Markus F. Neurath, Helmut Neumann

Item 1 - 10 / 50
1
2 3 4 5